Top Sell
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €39.15 | €56.86 | 45.241% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.24 | €50.00 | 1079.802% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €36.20 | €50.00 | 38.122% |
| Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
| Novavax Inc. | 4 | 2 | 1 | 0 | €4.41 | €8.00 | 81.529% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.32 | €26.71 | 116.841% |
| Arca Biopharma | 1 | 22 | 1 | 2 | €2.98 | €6.00 | 101.342% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.82 | €67.64 | 65.701% |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.58 | €3.00 | 413.523% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.08 | €3.65 | 236.982% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €28.25 | €38.00 | 34.491% |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.90 | - | - |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.45 | - | - |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.997% |
| Applied Therapeutics Inc | 1 | 1 | 0 | 1 | €4.52 | €4.00 | -11.583% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.06 | €3.00 | 45.773% |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.90 | - | - |
| AEterna Zentaris Inc. | 3 | 19 | 0 | 1 | €1.87 | €14.02 | 649.759% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Trevena Inc. | 1 | 14 | 0 | 2 | €0.36 | €8.37 | 2220.777% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €7.35 | €7.00 | -4.762% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.64 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |